Trial
NCT00478972
Japanese Study With Rimonabant in Obese Type 2 Diabetic Patients on Diet and Exercise
Phase IIITERMINATEDOPERATIONALConfidence: HIGH
Sponsor
Sanofi
Collaborators
—
Condition
Obesity
Intervention
Rimonabant
Why stopped
Company decision taken in light of demands by certain national health authorities
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2016-06-08